References
- Armstrong GL. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1):61–66. doi:10.1001/jama.281.1.61.
- Roush SW; Group and the V-PDTW. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155–63. doi:10.1001/jama.298.18.2155.
- McGovern ME, Canning D. Vaccination and all-cause child mortality from 1985 to 2011: global evidence from the demographic and health surveys. Am J Epidemiol. 2015;182:791–98. doi:10.1093/aje/kwv125.
- Phadke VK, Bednarczyk RA, Omer SB. Vaccine Refusal and Measles Outbreaks in the US. JAMA. 2020 Aug 14. [accessed 2020 Aug 31]. doi:10.1001/jama.2020.14828.
- Gardner L, Dong E, Khan K, Sarkar S. Persistence of US measles risk due to vaccine hesitancy and outbreaks abroad. Lancet Infect Dis. 2020 Jul 30. [accessed 2020 Aug 31]. doi:10.1016/S1473-3099(20)30522-3.
- Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M, Herring B, Kang Y, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:591–93. doi:10.15585/mmwr.mm6919e2.
- National Institutes of Health (NIH). Building trust in vaccines; 2019 Nov 25 [accessed 2020 Aug 31]. https://www.nih.gov/about-nih/what-we-do/science-health-public-trust/perspectives/science-health-public-trust/building-trust-vaccines
- [USC02] 42 USC CHAPTER 6A, SUBCHAPTER XIX: VACCINES. [accessed 2020 Aug 31]. https://uscode.house.gov/view.xhtml?path=/prelim@title42/chapter6A/subchapter19&edition=prelim
- Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the vaccine adverse event reporting system (VAERS). Vaccine. 2015;33:4398–405. doi:10.1016/j.vaccine.2015.07.035.
- Vaccine Adverse Event Reporting System (VAERS); 2020 Jul 23 [accessed 2020 Aug 31]. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html
- CDC. Clinical immunization safety assessment (CISA) project; 2020 Jul 7 [accessed 2020 Aug 31]. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/cisa/index.html
- Scherer LD, Shaffer VA, Patel N, Zikmund-Fisher BJ. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust? Vaccine. 2016;34(21):2424–29. doi:10.1016/j.vaccine.2016.03.087.
- Tau N, Yahav D, Shepshelovich D. Postmarketing safety of vaccines approved by the U.S. food and drug administration: a cohort study. Ann Intern Med. 2020 Jul 28 [[accessed 2020 Aug 31]];173(6):445–49. doi:10.7326/M20-2726.
- CDC. VPD-VAC/Rotavirus/Rotashield and Intussusception Historical info; 2019 Apr 15 [accessed 2020 Aug 31]. https://www.cdc.gov/vaccines/vpd-vac/rotavirus/vac-rotashield-historical.htm
- CDC. Withdrawal of rotavirus vaccine recommendation. [accessed 2020 Aug 31]. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4843a5.htm
- Tau N, Shochat T, Gafter-Gvili A, Tibau A, Amir E, Shepshelovich D. Association between data sources and us food and drug administration drug safety communications. JAMA Intern Med. 2019 Sep 3 [[accessed 2020 Aug 31]];179(11):1590. doi:10.1001/jamainternmed.2019.3066.
- Johns Hopkins Coronavirus Resource Center. COVID-19 map. [accessed 2020 Sep 6]. https://coronavirus.jhu.edu/map.html
- The Hill. Coleman J. COVID-19 now No. 3 cause of death in US; 2020 Aug 17 [accessed 2020 Aug 31]. https://thehill.com/policy/healthcare/512427-covid-19-now-no-3-cause-of-death-in-us
- World Bank. COVID-19 to plunge global economy into worst recession since world war II; 2020 Jun 8 [accessed 2020 Sep 3]. https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii
- Time. Bremmer I. The next global depression is coming and optimism won’t slow it down; 2020 Aug 6. [accessed 2020 Aug 31]. https://time.com/5876606/economic-depression-coronavirus/
- Oxford Law Faculty. Launch of report into child to parent violence during the pandemic; 2020 Aug 8. [accessed 2020 Aug 31]. https://www.law.ox.ac.uk/news/2020-08-18-launch-report-child-parent-violence-during-pandemic
- Calderón-Larrañaga A, Dekhtyar S, Vetrano DL, Bellander T, Fratiglioni L. COVID-19: risk accumulation among biologically and socially vulnerable older populations. Ageing Res Rev. 2020 Aug 17. [accessed 2020 Aug 31]. doi:10.1016/j.arr.2020.101149.
- Alcendor DJ. Racial disparities-associated COVID-19 mortality among minority populations in the US. J Clin Med. 2020 Jul 30. [accessed 2020 Aug 31]. doi:10.3390/jcm9082442.
- NCBI. Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1, complete genome; 2020 Jan 12. [accessed 2020 Aug 31]. http://www.ncbi.nlm.nih.gov/nuccore/MN908947.1
- WHO. Corman V, Bleicker T, Brünink S, Drosten C, Landt O, Koopmans M, Mc E, Zambon M. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT- PCR; 2020 Jan 13. [accessed 2020 Aug 31]. https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf?sfvrsn=d381fc88_2
- WHO. Draft landscape of COVID-19 candidate vaccines; 2020 Sep 3. [accessed 2020 Sep 3]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- Kaur SP, Gupta V. COVID-19Vaccine: a comprehensive status report. Virus Res. 2020 Aug 13. [accessed 2020 Aug 31]. doi:10.1016/j.virusres.2020.198114.
- Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA, Wirth DM, Chen A, Sack M, Pokorski JK, et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol. 2020;15:646–55. doi:10.1038/s41565-020-0737-y.
- Bregu M, Draper SJ, Hill AVS, Greenwood BM. Accelerating vaccine development and deployment: report of a royal society satellite meeting. Philos Trans R Soc Lond B Biol Sci. 2011;366:2841–49. doi:10.1098/rstb.2011.0100.
- IFPMA. The complex journey of a vaccine; 2014 Jan 17. [accesses 2020 Aug 31]. https://www.ifpma.org/resource-centre/the-complex-journey-of-a-vaccine-2/
- FDA Center for Biologics Evaluation and Research. Development and licensure of vaccines to prevent COVID-19; 2020 Jun 30. [accessed 2020 Aug 31]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
- ClinicalTrials.gov. Phase III double-blind, placebo-controlled study of AZD1222 for the prevention of COVID-19 in adults; 2020 Aug 18. [accessed 2020 Aug 31]. https://clinicaltrials.gov/ct2/show/NCT04516746
- ClinicalTrials.gov. A study to evaluate efficacy, safety, and immunogenicity of mRNA-1273 vaccine in adults aged 18 years and older to prevent COVID-19; 2020 Jul 14. [accessed 2020 Aug 31]. https://clinicaltrials.gov/ct2/show/NCT04470427
- Official website vaccine against COVID-19 Sputnik V. [accessed 2020 Aug 31]. https://sputnikvaccine.com/about-vaccine/
- TASS. Third stage of Russia’s coronavirus vaccine research may begin in 7-10 days; 2020 Aug 16. [accessed 2020 Aug 31]. https://tass.com/coronavirus-outbreak-in-china/1190127
- European Commission. Statement by Vice – president Jyrki Katainen on European Immunisation Week. Vaccination: time to speak out against disinformation; 2019 Apr 26 [accessed 2020 Aug 31]. https://ec.europa.eu/commission/presscorner/detail/en/STATEMENT_19_2254
- AP NEWS. AP-NORC poll: half of Americans would get a COVID-19 vaccine; 2020 May 28. [accessed 2020 Aug 31]. https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44
- Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82. doi:10.1007/s10198-020-01208-6.
- Verstraeten T, Cohet C, Dos Santos G, Ferreira GL, Bollaerts K, Bauchau V, Shinde V. PandemrixTM and narcolepsy: a critical appraisal of the observational studies. Hum Vaccin Immunother. 2016;12:187–93. doi:10.1080/21645515.2015.1068486.
- Edwards K, Lambert P-H, Black S. Narcolepsy and pandemic influenza vaccination: what we need to know to be ready for the next pandemic. Pediatr Infect Dis J. 2019;38:873–76. doi:10.1097/INF.0000000000002398.
- FDA. Office of the commissioner. Emergency use authorization; 2020 Aug 31 [accessed 2020 Aug 23]. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
- JAMA. COVID-19 and the FDA; 2020 Jul 30 [accessed 2020 Aug 31]. https://edhub.ama-assn.org/jn-learning/video-player/18529255